Skip to Content

Join the 'Pancreatic Cancer' group to help and get support from people like you.

Pancreatic Cancer News

Related terms: Cancer, Pancreas, Cancer, Pancreatic, Pancreatic Carcinoma

Alternative Medicine Alone as Cancer Treatment Linked to Lowered Survival

Posted 1 day 19 hours ago by Drugs.com

THURSDAY, Aug. 17, 2017 – People who choose alternative medicine over traditional cancer treatments for curable cancers have a higher risk of dying early, researchers report. "We now have evidence to suggest that using alternative medicine in place of proven cancer therapies results in worse survival," said study lead author Dr. Skyler Johnson from Yale School of Medicine and Yale Cancer Center. "It is our hope that this information can be used by patients and physicians when discussing the impact of cancer treatment decisions on survival," Johnson said in a school news release. Steve Jobs, co-founder and former CEO of Apple, is likely the most famous person who initially chose alternative medicine as a sole treatment. He eventually turned back to conventional medicine when the alternative medicine treatment didn't keep his pancreatic cancer at bay. But at that point, the cancer had ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Fluorouracil, Lupron Depot, Femara, Anastrozole, Letrozole, Evista, Pancreatic Cancer, Megestrol, Xeloda, Zoladex, Megace, Herceptin

More Patients OK'd for Cancer Trials Under Obamacare: Study

Posted 20 Jul 2017 by Drugs.com

THURSDAY, July 20, 2017 – The Affordable Care Act has enabled more privately insured patients to enroll in clinical trials for new cancer treatments, a new study contends. Speedy approvals are important for patients who want to participate in clinical trials, said study author Dr. David Hong. He's deputy chair of investigational cancer therapeutics at the University of Texas MD Anderson Cancer Center. Since 2000, Medicare, the publicly funded insurance program for seniors, has covered routine costs of clinical trial participation. But coverage for patients with private insurance differed by insurer and state, the researchers noted. Under the ACA, or Obamacare, however, private insurers had to cover "standard of care" costs of clinical trial participation as of 2014. For this study, the researchers analyzed more than 2,400 patient referrals to the Clinical Center for Targeted Therapy at ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Gleevec, Colorectal Cancer, Non-Small Cell Lung Cancer, Votrient, Avastin, Tarceva, Pancreatic Cancer, Tasigna, Sutent, Sprycel, Afinitor, Nexavar, Stomach Cancer, Carboplatin, Cisplatin, Cytoxan

Many Terminal Cancer Patients Remain in Denial

Posted 20 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – Nearly 10 percent of patients with terminal cancer don't want to know they're dying, which can make their final days more difficult, a new study finds. Unwillingness to face poor prospects can lead to unnecessary treatments and keep patients from making end-of-life plans, the researchers reported recently in The Oncologist. "Health care professionals should appropriately assess patients' readiness for prognostic information," said study leader Siew-Tzuh Tang, a professor at Chang Gung University School of Nursing in Taiwan. Doctors should respect patients' reluctance to confront their poor prognosis if they are not ready to know, "but sensitively coach them to cultivate their accurate prognostic awareness," Tang said in a journal news release. The study involved nearly 250 terminal cancer patients in Taiwan. They were questioned several times over their last ... Read more

Related support groups: Anxiety, Generalized Anxiety Disorder, Anxiety and Stress, Cancer, Post Traumatic Stress Disorder, Social Anxiety Disorder, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Pancreatic Cancer, Skin Cancer, Ovarian Cancer, Cervical Cancer, Stomach Cancer, Breast Cancer, Prevention

Doctors' Group Offers Ideas for Easing Cancer Costs

Posted 19 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society of Clinical Oncology (ASCO) has some suggestions for easing patients' money woes. The proposals include allowing Medicare to negotiate drug prices, legalizing the importation of drugs, and adopting bundled, or group, payment programs. In the new policy statement, ASCO also says it supports creation of a panel of "stakeholders" in health care to determine the effectiveness of its proposals. Such a group might also outline a uniform approach for assessing the value of drugs. "In what, undoubtedly, is one of the most difficult times in their lives, individuals with cancer should be focused on getting the best care possible, not worrying about financial strain on their families," said Dr. Clifford Hudis. He's CEO of ASCO, a leading ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Arimidex, Fluorouracil, Lupron Depot, Femara, Lung Cancer, Gleevec, Colorectal Cancer, Votrient, Anastrozole, Brain Tumor, Letrozole

New Test May Help Spot Pancreatic Cancer Early

Posted 12 Jul 2017 by Drugs.com

WEDNESDAY, July 12, 2017 – A new, low-cost blood test may be an effective way to detect pancreatic cancer early, a research team says. The nation's No. 4 cancer killer, pancreatic cancer often goes undiagnosed until it is too far along to remove. Current screening techniques typically catch it only "after it causes pronounced symptoms, when it has advanced far enough to be lethal," said study author Kenneth Zaret, director of the University of Pennsylvania's Institute for Regenerative Medicine. Sometimes it's found during a body scan for another health issue. But such scans are too costly for routine screening, even for people with a high risk of pancreatic cancer, he said. That includes parents, siblings or children of people who have had pancreatic cancer; those with some gene mutations; and people over 50 who suddenly develop diabetes. "A low-cost, noninvasive test, such as we have ... Read more

Related support groups: Pancreatitis, Chronic Pancreatitis, Pancreatic Cancer, Diagnosis and Investigation, Body Imaging

Blood Test for Pancreatic Cancer Shows Early Promise

Posted 24 May 2017 by Drugs.com

WEDNESDAY, May 24, 2017 – Scientists say they've developed a new blood test for identifying pancreatic cancer – a step that might eventually allow earlier diagnosis. Pancreatic cancer is a particularly deadly type of tumor because it's often detected too late for effective treatment. The still-experimental test detects a bundle of proteins churned out by pancreatic tumors. And it appears to be more accurate than a currently available test for a protein called CA19-9, according to the study findings. That CA 19-9 test is "very imperfect," said Dr. Cesar Castro, one of the researchers on the new study. For one, levels of CA 19-9 often rise only in the later stages of pancreatic cancer, according to Castro, an oncologist at Massachusetts General Hospital in Boston. Plus, a spike in the protein is not specific to the cancer. It can go up when the pancreas is inflamed, for example, or when ... Read more

Related support groups: Cancer, Breast Cancer, Colonoscopy, Colorectal Cancer, Pancreatic Cancer

Not All Hospitals Equal When It Comes to Pancreatic Cancer Care

Posted 8 May 2017 by Drugs.com

MONDAY, May 8, 2017 – When it comes to treating pancreatic cancer, where you have your surgery may have some impact on how long you live, according to a new study. The researchers found that people who travel to an academic medical center to undergo surgery for pancreatic cancer live a few months longer than those who choose to have their operation at a hospital closer to home. High-volume surgical centers also tended to provide better care for patients with pancreatic or thyroid cancer, but few people opt to travel for their surgery, the study authors said. "Little was known about whether traveling to receive surgical cancer care results in differences in perioperative outcomes and overall survival," said senior investigator Dr. Raymon Grogan. He is an assistant professor of surgery at the University of Chicago Medicine. "Yet, there is a well-established relationship between a ... Read more

Related support groups: Thyroid Cancer, Pancreatic Cancer, Diagnosis and Investigation

Survival Continues to Improve for Most Cancers

Posted 31 Mar 2017 by Drugs.com

FRIDAY, March 31, 2017 – Overall cancer death rates in the United States continue to fall, but racial gaps persist, a new report says. Death rates fell between 2010 and 2014 for 11 of the 16 most common cancers in men and for 13 of the most common types in women, including lung, colon, prostate and breast cancers. However, death rates rose for cancers of the liver, pancreas and brain in men and for the liver and uterus in women. And improvements in cancer survival weren't equal for all Americans. "While this report found that five-year survival for most types of cancer improved among both blacks and whites over the past several decades, racial disparities for many common cancers have persisted, and they may have increased for prostate cancer and female breast cancer," said Dr. Lynne Penberthy. She's associate director of the U.S. National Cancer Institute's Surveillance Research ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Melanoma, Pancreatic Cancer, Skin Cancer, Ovarian Cancer, Endometrial Cancer, Osteosarcoma, Small Cell Lung Cancer, Cervical Cancer, Breast Cancer - Adjuvant, Bladder Cancer, Melanoma - Metastatic

Another Study Ties Obesity to Certain Cancers

Posted 1 Mar 2017 by Drugs.com

WEDNESDAY, March 1, 2017 – Carrying extra weight increases the risk of a number of cancers, a new review reports. Additional pounds appear to particularly influence the risk of cancers related to the digestive organs or those driven by hormonal abnormalities, according to the review's European authors. The evidence is so strong at this point that important organizations such as the International Agency for Research on Cancer describe "excess body weight as an important cause of cancers," said Susan Gapstur. She's vice president of epidemiology at the American Cancer Society. The new evidence review was led by Maria Kyrgiou, of Imperial College London's Department of Surgery and Cancer. The review found that a jump in a person's body mass index (BMI) of 5 was associated with a higher cancer risk in the esophagus, bone marrow, biliary tract system, pancreas and kidneys. BMI is a rough ... Read more

Related support groups: Obesity, Cancer, Weight Loss, Breast Cancer, Prostate Cancer, Renal Cell Carcinoma, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Endometrial Cancer, Stomach Cancer, Gastric Cancer, Wilms' Tumor, Solid Tumors, Peritoneal Cancer, Neoplasm of Bone, Insulinoma, Giant Cell Tumor of Bone

Is There a Link Between Diabetes and Pancreatic Cancer?

Posted 31 Jan 2017 by Drugs.com

TUESDAY, Jan. 31, 2017 – Developing or worsening type 2 diabetes could be an early sign of pancreatic cancer, new research suggests. Researchers analyzed data from nearly a million patients with type 2 diabetes or pancreatic cancer in Italy and Belgium. Half of all pancreatic cancer cases were diagnosed within a year of patients being diagnosed with diabetes, the findings showed. The investigators also found that type 2 diabetes patients whose condition deteriorated rapidly requiring more aggressive treatment were also at increased risk for pancreatic cancer. The study findings, which don't prove an association between type 2 diabetes and pancreatic cancer, were presented Monday at the European Cancer Congress (ECC) in Amsterdam. Research presented at medical meetings is typically considered preliminary until published in a peer-reviewed journal. "Doctors and their diabetic patients ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Lantus, Glipizide, Glucophage, Novolog, Humalog, Janumet, Glyburide, Levemir, Lantus Solostar, Glimepiride, Pancreatic Cancer, Novolin R, Amaryl, Novolin N, Humulin N, Glucophage XR, Lantus Solostar Pen

Mental Health May Affect Chances Against Cancer

Posted 26 Jan 2017 by Drugs.com

WEDNESDAY, Jan. 25, 2017 – Anxiety and depression may increase the risk of death from certain cancers, early research suggests. After analyzing studies involving thousands of patients in Great Britain, researchers found that people with greater levels of psychological distress had higher death rates for colon, esophageal, pancreatic and prostate cancers and leukemia. The study was published Jan. 25 in the BMJ. "Our findings contribute to the evidence that poor mental health might have some predictive capacity for certain physical diseases, but we are a long way off from knowing if these relationships are truly causal," said researcher David Batty in a journal news release. Batty is with University College London. He and his colleagues reviewed 16 English and Scottish studies that included more than 163,000 people, aged 16 and older. The people were initially cancer-free and followed ... Read more

Related support groups: Depression, Anxiety, Anxiety and Stress, Major Depressive Disorder, Prostate Cancer, Colorectal Cancer, Dysthymia, Psychiatric Disorders, Pancreatic Cancer, Head and Neck Cancer

Daily Low-Dose Aspirin May Cut Pancreatic Cancer Risk

Posted 20 Dec 2016 by Drugs.com

TUESDAY, Dec. 20, 2016 – There's evidence that daily low-dose aspirin may decrease the risk of pancreatic cancer, according to a new study. The Chinese-based study couldn't prove cause-and-effect. However, "the balance of evidence shows that people who use aspirin to reduce risk for cardiovascular disease or colorectal cancer can feel positive that their use likely also lowers their risk for pancreatic cancer," said study lead author Dr. Harvey Risch. He's professor of epidemiology at the Yale School of Public Health and Yale Cancer Center in New Haven, Conn. According to the American Cancer Society, about 53,000 Americans will be diagnosed with pancreatic cancer this year, and almost 42,000 will die from the disease. Pancreatic cancer is often a "silent killer" because symptoms do not emerge until the tumor is advanced. The new study tracked 761 people diagnosed with pancreatic cancer ... Read more

Related support groups: Aspirin, Excedrin, Colorectal Cancer, Pancreatic Cancer, Aggrenox, Alka-Seltzer, Fiorinal, Excedrin Migraine, Arthritis Pain, Prevention of Cardiovascular Disease, Ecotrin, Cardiovascular Risk Reduction, Fiorinal with Codeine, Soma Compound, Norgesic, Bayer Aspirin, Arthritis Pain Formula, Excedrin Extra Strength, Norgesic Forte, Percodan

Women's Cancer Risk Rises With Years Spent Overweight

Posted 16 Aug 2016 by Drugs.com

TUESDAY, Aug. 16, 2016 – The longer a woman is overweight, the higher her risk of several cancers, researchers report. The study, which followed nearly 74,000 U.S. women, found that the longer a woman carried excess poundage, the greater her risk of breast, endometrial, colon and kidney cancers. "We've known for a long time that excess weight is important in cancer risk," said Susan Gapstur, vice president of epidemiology for the American Cancer Society. The cancer society says excess weight contributes to as many as 20 percent of all cancer deaths. "This study is interesting because it suggests that the number of years you spend being overweight also matters," said Gapstur, who was not involved in the research. And that, she said, should provide further incentive to avoid excess weight gain in the first place. Currently, about 7 out of 10 adults in the United States are overweight, ... Read more

Related support groups: Obesity, Cancer, Weight Loss, Breast Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Bladder Cancer, Urinary Tract Cancer

Health Insurance Status May Affect Cancer Patients' Survival

Posted 8 Aug 2016 by Drugs.com

MONDAY, Aug. 8, 2016 – Two large studies suggest that surviving certain cancers in America could depend on your health insurance status. Despite improvements in cancer diagnosis and treatment, patients who were uninsured or had Medicaid coverage were more likely to suffer worse outcomes, compared with people who have other forms of health insurance, the studies found. People who were uninsured or relied on Medicaid were diagnosed at a later stage, received sub-optimal treatment and had shorter survival, the findings showed. In the case of testicular cancer, they were at greater risk of death from their disease than patients with other insurance, the researchers found. The findings, published online Aug. 8 in the journal Cancer, add to evidence linking poor outcomes and inadequate health insurance. Dr. Christopher Sweeney, a medical oncologist at the Dana-Farber Cancer Institute in ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Basal Cell Carcinoma, Brain Tumor, Melanoma, Pancreatic Cancer, Skin Cancer, Ovarian Cancer, Cervical Cancer, Melanoma - Metastatic

New Guidelines Issued for Cancer Patients' Post-Treatment Pain

Posted 29 Jul 2016 by Drugs.com

FRIDAY, July 29, 2016 – More people are surviving cancer, but many are left with persistent pain after treatment. New guidelines from the American Society of Clinical Oncology (ASCO) recommend that doctors routinely screen for such pain. The guidelines also advise doctors to consider the use of non-traditional treatments for pain. These include hypnosis, meditation and medical marijuana where it's legal. ASCO also cautioned doctors to assess patients' risk for overuse of opioid painkillers. "Many oncologists and primary care physicians are not trained to recognize or treat long-term pain associated with cancer," guideline panel co-chair Judith Paice said in an ASCO news release. "This guideline will help clinicians identify pain early and develop comprehensive treatment plans, using a broad range of approaches," she said. Advances in cancer diagnosis and treatment have led to a record ... Read more

Related support groups: Pain, Suboxone, Oxycodone, Hydrocodone, Tramadol, Chronic Pain, Percocet, Methadone, Cancer, OxyContin, Vicodin, Norco, Fentanyl, Morphine, Codeine, Lortab, Tylenol, Opana, Ibuprofen, Naproxen

Page 1 2 3 4 5 6 7 Next

Ask a Question

Further Information

Related Condition Support Groups

Cancer

Related Drug Support Groups

methotrexate, fluorouracil, Tarceva, Sutent, Afinitor, capecitabine, gemcitabine, Gemzar, sunitinib, view more... mitomycin, erlotinib, everolimus, pancreatin, Abraxane, bevacizumab, cetuximab, Adrucil, Onivyde, paclitaxel protein-bound, streptozocin, irinotecan liposomal, Mutamycin, Zanosar